Isis Pharmaceuticals (ISIS) – Bull of the Day
Source: http://www.zacks.com/commentary/9647/Isis+Pharmaceuticals+%28ISIS%29+-+Bull+of+the+DayPosted on Sunday, January 4th, 2009 | In Stocks to Watch
Isis Pharmaceuticals, Inc. (ISIS) is a drug discovery and development company focused on the therapeutic target RNA and developing products from RNA-based technologies, such as “antisense.” We believe that antisense technology represents an exciting and potentially revolutionary platform for developing therapeutic candidates to treat a wide margin of diseases.
The company’s leading candidates are mipomersen for high cholesterol and ISIS-113715 for diabetes, along with several other proprietary and partnered programs for oncology, inflammatory disease, asthma, and viral infections. Our financial model forecasts sustained profitability in 2011.
We are reiterating or rating on Isis Pharmaceuticals of a Buy and maintaining our price target of $22.
“ISIS” Free Stock Analysis: Buy? Sell? Hold?
“LF” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research
Last 5 posts by Zacks Market Commentaries
- CNP & FPL Ink Pipeline Deal - Analyst Blog - November 20th, 2009
- Buffett Borrows for Rail Acquisition - Analyst Blog - November 20th, 2009
- Stone Energy Outdoes Estimates - Analyst Blog - November 20th, 2009
- Smucker's Beats, Raises Guidance - Analyst Blog - November 20th, 2009
- GameStop Meets Expectations - Analyst Blog - November 20th, 2009
antisense technology;, asthma, Day Isis Pharmaceuticals Inc.;, Diabetes, Drug Discovery, Isis Pharmaceuticals;, RNA-based technologies;, Stocks to Watch, USD, Zacks Market Commentaries
 About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.